Cloosterman, S.; Wijnands, I.; Huygens, S.; Wester, V.; Lam, K.-H.; Strijbis, E.; den Teuling, B.; Versteegh, M.
The Potential Impact of Digital Biomarkers in Multiple Sclerosis in The Netherlands: An Early Health Technology Assessment of MS Sherpa. Brain Sci. 2021, 11, 1305.
https://doi.org/10.3390/brainsci11101305
AMA Style
Cloosterman S, Wijnands I, Huygens S, Wester V, Lam K-H, Strijbis E, den Teuling B, Versteegh M.
The Potential Impact of Digital Biomarkers in Multiple Sclerosis in The Netherlands: An Early Health Technology Assessment of MS Sherpa. Brain Sciences. 2021; 11(10):1305.
https://doi.org/10.3390/brainsci11101305
Chicago/Turabian Style
Cloosterman, Sonja, Inez Wijnands, Simone Huygens, Valérie Wester, Ka-Hoo Lam, Eva Strijbis, Bram den Teuling, and Matthijs Versteegh.
2021. "The Potential Impact of Digital Biomarkers in Multiple Sclerosis in The Netherlands: An Early Health Technology Assessment of MS Sherpa" Brain Sciences 11, no. 10: 1305.
https://doi.org/10.3390/brainsci11101305
APA Style
Cloosterman, S., Wijnands, I., Huygens, S., Wester, V., Lam, K.-H., Strijbis, E., den Teuling, B., & Versteegh, M.
(2021). The Potential Impact of Digital Biomarkers in Multiple Sclerosis in The Netherlands: An Early Health Technology Assessment of MS Sherpa. Brain Sciences, 11(10), 1305.
https://doi.org/10.3390/brainsci11101305